Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

PhRMA Studies Contest AARP Drug Price “Watchdog Report”

Executive Summary

Prescription drug prices rose only 0.9% in the first quarter of 2004, not 3.4% as AARP claims, a study of Bureau of Labor Statistics data commissioned by the Pharmaceutical Research & Manufacturers of America says

You may also be interested in...



Price Increases For Branded Drugs Slower Since Medicare Drug Card – AARP

The prices pharmaceutical manufacturers charge wholesalers for brand name drugs have been increasing at a slower rate since the Medicare drug discount card became available, AARP concludes in an "Rx Watchdog Report" released April 12

Price Increases For Branded Drugs Slower Since Medicare Drug Card – AARP

The prices pharmaceutical manufacturers charge wholesalers for brand name drugs have been increasing at a slower rate since the Medicare drug discount card became available, AARP concludes in an "Rx Watchdog Report" released April 12

Rx Prices For Medicare, Non-Medicare Groups Show Similar Growth – GAO

Retail prices for drugs frequently used by Medicare enrollees are increasing at a "similar" rate to those used by the non-Medicare population, the Government Accountability Office said

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS044730

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel